<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04777812</url>
  </required_header>
  <id_info>
    <org_study_id>P-MAPS_02794</org_study_id>
    <nct_id>NCT04777812</nct_id>
  </id_info>
  <brief_title>Pancreatitis - Microbiome As Predictor of Severity</brief_title>
  <acronym>P-MAPS</acronym>
  <official_title>Pancreatitis - Microbiome As Predictor of Severity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Goettingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Medicine II, University Hospital Rostock</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Department II, Division of Gastroenterology, University Hospital of Leipzig</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Medicine II, University Hospital, LMU Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Medicine I, University Hospital of Halle</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Medicine A, University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Medicine II, University Hospital rechts der Isar, Technical University Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department of Medical Bioinformatics, University Medical Center Göttingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Department if Medical Statistics, University Medical Center Göttingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Medical Center Goettingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multicentric prospective study initiated and coordinated from the University&#xD;
      Medical Centre Goettingen. The study aims to evaluate the orointestinal microbiome as a&#xD;
      potential biomarker for the course, severity and outcome of patients with acute pancreatitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective translational study aims to evaluate the orointestinal microbiome as a&#xD;
      potential biomarker for the course, severity and outcome of patients with acute pancreatitis.&#xD;
      From each patient one buccal and rectal swab is collected within 72 h after hospital&#xD;
      admission. Microbial composition will be determined by 16S and metagenomics Oxford Nanopore&#xD;
      Sequencing (ONT) and correlated with the revised Atlanta classification as the primary&#xD;
      endpoint. Secondary endpoints are the correlation of microbiome signatures with the length of&#xD;
      hospital stay, numbers of interventions and mortality. To this end, alpha and beta diversity&#xD;
      of microbiota are determined and compared between mild, moderately severe and severe acute&#xD;
      pancreatitis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 17, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Revised Atlanta classification I-III</measure>
    <time_frame>up to 8 weeks</time_frame>
    <description>Microbial composition (alpha and beta-diversity) will be correlated with the revised Atlanta classification.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>up to 12 months</time_frame>
    <description>days in hospital during initial admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numbers of interventions (surgical and endoscopical)</measure>
    <time_frame>up to 12 months</time_frame>
    <description>number of percutaneous drainages, number of EUS-guided interventions of infected necrotic or acute collections, type of drainages (plastic versus lumen apposing metal stents), number of open surgical interventions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>up to 12 months</time_frame>
    <description>in hospital mortality during initial admission (%)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Acute Pancreatitis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Rectal and buccal swabs</intervention_name>
    <description>The oral and intestinal flora is collected from buccal and rectal swabs.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with acute pancreatitis (2 out of 3 following diagnostic criteria: lipase &gt;3x of&#xD;
        upper limit, abdominal pain, and imaging modalities (computed tomography, magnetic&#xD;
        resonance imaging or ultrasound).&#xD;
&#xD;
        &lt; 72 hours after hospital admission.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Pregnant women Patients &lt; 18 years; Patients who are incapable of giving consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Albrecht Neesse, MD, PhD</last_name>
    <phone>0049 551 39</phone>
    <phone_ext>62313</phone_ext>
    <email>albrecht.neesse@med.uni-goettingen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Centre Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volker Ellenrieder, MD</last_name>
      <phone>0049 551 39</phone>
      <phone_ext>62313</phone_ext>
      <email>volker.ellenrieder@med.uni-goettingen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Ammer-Herrmenau C, Pfisterer N, Weingarten MF, Neesse A. The microbiome in pancreatic diseases: Recent advances and future perspectives. United European Gastroenterol J. 2020 Oct;8(8):878-885. doi: 10.1177/2050640620944720. Epub 2020 Jul 23. Review.</citation>
    <PMID>32703080</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2021</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Goettingen</investigator_affiliation>
    <investigator_full_name>Albrecht Neesse</investigator_full_name>
    <investigator_title>Prof. Dr. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

